AARDVARK THERAPEUTICS Trademark

Trademark Overview

On Saturday, November 16, 2024, a trademark application was filed for AARDVARK THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the AARDVARK THERAPEUTICS trademark a serial number of 98857292. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Tuesday, June 24, 2025. This trademark is owned by AARDVARK THERAPEUTICS, INC.. The AARDVARK THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Therapeutic pharmaceuticals for the treatment of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; therapeutic pharmaceuticals for cancer treatment and management; abuse-deterrent pharmaceutical preparations for treatment of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity.

Medical and scientific research and development in the fields of diagnosis and treatment of neuro-psychological disorders, autism, metabolic and inflammatory conditions, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; providing medical and scientific research information in the fields of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; medical and scientific research, namely, conducting clinical trials for others for pharmaceuticals, drug development, and therapeutic applications in the fields of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; clinical research in the field of neuro-psychological disorders, autism, metabolic and inflammatory diseases, and obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity.
aardvark therapeutics

General Information

Serial Number98857292
Word MarkAARDVARK THERAPEUTICS
Filing DateSaturday, November 16, 2024
Status680 - APPROVED FOR PUBLICATION
Status DateTuesday, June 24, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesTherapeutic pharmaceuticals for the treatment of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; therapeutic pharmaceuticals for cancer treatment and management; abuse-deterrent pharmaceutical preparations for treatment of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity.
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesMedical and scientific research and development in the fields of diagnosis and treatment of neuro-psychological disorders, autism, metabolic and inflammatory conditions, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; providing medical and scientific research information in the fields of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; medical and scientific research, namely, conducting clinical trials for others for pharmaceuticals, drug development, and therapeutic applications in the fields of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; clinical research in the field of neuro-psychological disorders, autism, metabolic and inflammatory diseases, and obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, November 16, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, November 16, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAARDVARK THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92122

Trademark Events

Event DateEvent Description
Saturday, November 16, 2024NEW APPLICATION ENTERED
Saturday, April 26, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 12, 2025ASSIGNED TO EXAMINER
Wednesday, May 14, 2025NON-FINAL ACTION WRITTEN
Monday, June 23, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 24, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 24, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 23, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 14, 2025NON-FINAL ACTION E-MAILED
Wednesday, May 14, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

therapeutics aardvark disorders obesity metabolic inflammatory prader syndrome willi hypothalamic autism neuro